2023 annual financial data
Neumora Therapeutics 2023 Operating cash flow margin
Direct answer
Operating cash flow margin was Not calculable.
Operating income was -188,194,000 USD and net income was -235,925,000 USD.
Operating cash flow was -163,278,000 USD.
Get free Neumora Therapeutics email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 0 USD
- Operating income
- -188,194,000 USD
- Net income
- -235,925,000 USD
- Operating cash flow
- -163,278,000 USD